We are live on
!
Find out more
Axa Portfolio holdings
AUM
$256M
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
+2.39%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$18.8B
AUM Growth
–
Cap. Flow
+$18.6B
Cap. Flow
% of AUM
98.77%
Top 10 Holdings %
Top 10 Hldgs %
14.87%
Holding
1,277
New
1,254
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$355M |
| 2 |
Apple
AAPL
|
+$344M |
| 3 |
Chevron
CVX
|
+$323M |
| 4 |
JPMorgan Chase
JPM
|
+$296M |
| 5 |
ExxonMobil
XOM
|
+$285M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.07% |
| 2 | Financials | 12.69% |
| 3 | Technology | 11.8% |
| 4 | Energy | 9.95% |
| 5 | Industrials | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pfizer
PFE
$144B
| $342M | 1.81% |
+12,852,527
| New | +$355M |
|
|
2
Chevron
CVX
$383B
| $316M | 1.68% |
+2,672,778
| New | +$323M |
|
|
3
Apple
AAPL
$5T
| $316M | 1.68% |
+22,336,748
| New | +$344M |
|
|
4
JPMorgan Chase
JPM
$928B
| $308M | 1.63% |
+5,829,843
| New | +$296M |
|
|
5
ExxonMobil
XOM
$653B
| $287M | 1.52% |
+3,171,733
| New | +$285M |
|
6
Walmart Inc
WMT
$906B
| $256M | 1.36% |
+10,301,163
| New | +$264M |
|
7
Amgen
AMGN
$210B
| $242M | 1.28% |
+2,450,241
| New | +$254M |
|
8
Wells Fargo
WFC
$258B
| $234M | 1.25% |
+5,681,041
| New | +$221M |
|
9
Microsoft
MSFT
$2.93T
| $233M | 1.24% |
+6,755,017
| New | +$221M |
|
10
Alphabet (Google) Class C
GOOG
$4.09T
| $232M | 1.23% |
+10,569,630
| New | +$224M |
|
11
Oracle
ORCL
$339B
| $229M | 1.22% |
+7,463,996
| New | +$248M |
|
12
Home Depot
HD
$341B
| $224M | 1.19% |
+2,889,552
| New | +$217M |
|
13
Comcast
CMCSA
$87.2B
| $215M | 1.14% |
+10,255,344
| New | +$212M |
|
14
Medtronic
MDT
$113B
| $201M | 1.07% |
+3,905,025
| New | +$193M |
|
15
CVS Health
CVS
$137B
| $187M | 1% |
+3,276,967
| New | +$190M |
|
16
Johnson & Johnson
JNJ
$645B
| $185M | 0.98% |
+2,153,252
| New | +$183M |
|
17
Union Pacific
UNP
$173B
| $180M | 0.96% |
+2,332,382
| New | +$176M |
|
18
UnitedHealth
UNH
$386B
| $176M | 0.93% |
+2,681,322
| New | +$167M |
|
19
IBM
IBM
$213B
| $172M | 0.91% |
+938,929
| New | +$183M |
|
20
Deutsche Bank
DB
$67.9B
| $169M | 0.9% |
+4,711,774
| New | +$179M |
|
21
Eli Lilly
LLY
$1.09T
| $166M | 0.88% |
+3,381,449
| New | +$184M |
|
22
APA Corp
APA
$12.8B
| $159M | 0.84% |
+1,892,307
| New | +$150M |
|
|
DFS
23
DELISTED
Discover Financial Services
DFS
| $152M | 0.81% |
+3,190,167
| New | +$146M |
|
|
MRO
24
DELISTED
Marathon Oil Corporation
MRO
| $150M | 0.8% |
+4,348,190
| New | +$147M |
|
25
GE Aerospace
GE
$365B
| $133M | 0.71% |
+1,194,808
| New | +$132M |
|
Similar funds
PHAM
HFRG
EBWM
GCCM
CIA
KAM
ACM
CCA
Axa's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Axa, which disclosed 1,277 positions worth $18.8B. Its ten largest holdings account for 15% of the portfolio.
Its largest position is Pfizer: 12,852,527 shares worth $342M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, followed by Financials and Technology.
- Axa's largest Q2 2013 buy was Pfizer: 12,852,527 shares worth $342M.
- Axa's ten largest holdings make up 15% of its $18.8B portfolio in Q2 2013.
- Axa disclosed 1,277 positions in Q2 2013, its first 13F filing on record.
Based on Axa's 13F filing for Q2 2013, filed 12 Aug 2013.